Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,521 to 1,540 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation. | Mol Biol Cell | 2017 | 28228552 | PubTator, text mining | PubMed |
| Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial. | J Clin Pharmacol | 2017 | 28218410 | PubTator, text mining | PubMed |
| Elf5 is a principal cell lineage specific transcription factor in the kidney that contributes to Aqp2 and Avpr2 gene expression. | Dev Biol | 2017 | 28215940 | PubTator, text mining | PubMed |
| Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease. | Pediatr Nephrol | 2017 | 28194574 | PubTator, text mining | PubMed |
| Hyponatremia and cyst growth in neonatal polycystic kidney disease: a case for aquaretics? | Pediatr Nephrol | 2017 | 28194573 | PubTator, text mining | PubMed |
| Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells. | Front Oncol | 2017 | 28194370 | PubTator, text mining | PubMed |
| Cyclic-AMP regulates postnatal development of neural and behavioral responses to NaCl in rats. | PLoS One | 2017 | 28192441 | PubTator, text mining | PubMed |
| Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure. | Clin Exp Nephrol | 2017 | 28190113 | PubTator, text mining | PubMed |
| Aquaporin-2 membrane targeting: still a conundrum. | Am J Physiol Renal Physiol | 2017 | 28179252 | PubTator, text mining | PubMed |
| Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease. | Am J Nephrol | 2017 | 28166521 | PubTator, text mining | PubMed |
| Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis. | Sci Rep | 2017 | 28165501 | PubTator, text mining | PubMed |
| Where does axon guidance lead us? | F1000Res | 2017 | 28163913 | PubTator, text mining | PubMed |
| Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide. | Sci Rep | 2017 | 28145450 | PubTator, text mining | PubMed |
| Nephrogenic diabetes insipidus. | Curr Opin Pediatr | 2017 | 28134709 | PubTator, text mining | PubMed |
| Stem Cell Plasticity and Niche Dynamics in Cancer Progression. | IEEE Trans Biomed Eng | 2017 | 28113244 | PubTator, text mining | PubMed |
| Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis. | Mol Cancer Res | 2017 | 28108623 | PubTator, text mining | PubMed |
| Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome. | Intern Med | 2017 | 28090051 | PubTator, text mining | PubMed |
| Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment. | PLoS One | 2017 | 28081165 | PubTator, text mining | PubMed |
| The spinal cord shows the way - How axons navigate intermediate targets. | Dev Biol | 2017 | 27965053 | PubTator, text mining | PubMed |
| Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial. | J Am Soc Nephrol | 2017 | 27920153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=77